Average Co-Inventor Count = 3.96
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Biogen Ma Inc. (6 from 250 patents)
2. Biogen Idec Ma Inc. (4 from 216 patents)
3. Q32 Bio Inc. (3 from 3 patents)
4. Other (2 from 832,843 patents)
5. Curis, Inc. (2 from 141 patents)
6. Ucb Biopharma Sprl (2 from 138 patents)
7. Ucb Pharma, S.a. (1 from 179 patents)
8. Biogen Idec, Inc. (1 from 46 patents)
9. Stephen Trosper (1 from 1 patent)
18 patents:
1. 11879008 - Methods of treating complement mediated diseases with fusion protein constructs comprising anti-C3d antibody and a complement modulator
2. 11571477 - Anti-VLA-4 antibodies
3. 11083791 - Anti-VLA-4 antibodies
4. 11053305 - Fusion protein constructs comprising anti-C3d antibody and CR1 polypeptide
5. 11053306 - Fusion protein constructs comprising anti-C3d antibody and factor H
6. 10335485 - Anti-VLA-4 antibodies
7. 9902775 - Anti-blood dendritic cell antigen 2 antibodies and uses thereof
8. 9738707 - Heterodimeric Fc regions, binding molecules comprising same, and methods relating thereto
9. 9321840 - Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof
10. 8784823 - Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof
11. 8318917 - Nucleic acids encoding antibodies having altered effector function and methods for making the same
12. 8293237 - Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof
13. 7863419 - Antibodies having altered effector function and methods for making the same
14. 7479539 - Hedgehog fusion proteins
15. 6897297 - Hydrophobically-modified protein compositions and methods